據報廣汽及吉利等共同投資汽車芯片公司
據內地媒體引述企業徵信機構天眼查資料顯示,(王金)捷電子關聯公司南京英銳創電子科技有限公司近日發生工商變更,股東新增中國國有企業混合所有制改革基金有限公司、廣汽(02238.HK)(601238.SH)旗下廣東廣祺越秀智源產業投資基金合伙企業(有限合伙)及吉利(00175.HK)旗下吉利共創伍號投資(天津)合伙企業(有限合伙)等多家企業。
該公司註冊資本由約443.29萬人民幣增至約511.42萬人民幣,增幅約15.37%。經營範圍包括半導體集成電路、膜集成電路、汽車集成電路芯片、工業集成電路芯片、醫療電子芯片的設計、研發及銷售等。(ta/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.